Pamela Vig

Pam Vig, Ph.D., is chief scientific officer for Mirum Pharmaceuticals, a company focused on rare liver diseases, where she leads scientific and clinical aspects of drug development, research, and medical affairs. Dr. Vig holds a Ph.D. from Imperial College London from the departments of hepatology and histopathology.  

  Dr. Vig has more than 27 years of industry experience in clinical development, medical affairs and translational science in various liver diseases and infectious diseases including HIV, HBV, HCV, NASH as well as adult and pediatric cholestatic liver diseases. Before joining Mirum, Pam held leadership roles at several companies including Allergan/Tobira Therapeutics, Presidio Pharmaceuticals, JNJ/Tibotec, Idenix Pharmaceuticals, Viropharma, Gilead Sciences and Chiron Corporation. Pam is a member of the PSC Forum Steering Committee as well as co-chair for the pediatric cholestatic disease working group under the Forum for Collaborative Research.